VentureMed Group, Inc., an innovative medical device company specializing in vessel preparation and access management for AV fistulas and grafts and peripheral vascular disease, today announced it is ...
This retrospective analysis compares the efficacy of three endovascular treatment modalities in the treatment of vascular access stenoses: 1) plain-balloon angioplasty + drug coated balloon ...
MINNEAPOLIS, March 5, 2026 /PRNewswire/ -- VentureMed Group, Inc., an innovative medical device company specializing in vessel preparation and access management for AV fistulas and grafts and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results